title: Treatment of adenocarcinoma of the liver with mitomycin, hyaluronidase, and ethanol: an experimental study in the rat.
abstract: OBJECTIVE
  To evaluate the effect of intratumorally injected ethanol, mitomycin, mitomycin with hyaluronidase, and hyaluronidase on tumor growth in an experimental model.
  
  
  METHODS
  A suspension of 1 x 10(6) cells of chemically induced adenocarcinoma was implanted into the liver of 52 rats. Seven days later the rats were divided into groups according to treatment and injected via a midline laparotomy with ethanol, mitomycin, mitomycin with hyaluronidase, or hyaluronidase. A control group was treated with saline. The rats were killed 7 days after treatment. The tumor growth ratio was calculated, and the results compared for the different groups. Wilcoxon's rank sum test was used for statistical evaluation.
  
  
  RESULTS
  The tumor growth ratio was significantly reduced after injection of mitomycin (p < 0.01) but not after ethanol. Hyaluronidase alone did not reduce the tumor growth ratio and had no synergetic effect with mitomycin.
  
  
  CONCLUSIONS
  In an animal model intratumoral treatment of adenocarcinoma of the liver with mitomycin was significantly more efficient than similar treatment with saline or ethanol.
authors.affiliation: Department of Diagnostic Radiology, University Hospital Lund, S-22185 Sweden.
authors.forename: J
authors.initials: J
authors.lastname: Harnek
authors.forename: W
authors.initials: W
authors.lastname: Cwikiel
authors.forename: E
authors.initials: E
authors.lastname: Zoucas
authors.forename: B
authors.initials: B
authors.lastname: Seiving
authors.forename: U
authors.initials: U
authors.lastname: Stenram
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000473:pathology; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use*; D002455:Cell Division / Q000187:drug effects; D004359:Drug Therapy, Combination; D000431:Ethanol / Q000008:administration & dosage / Q000627:therapeutic use*; D006821:Hyaluronoglucosaminidase / Q000008:administration & dosage / Q000627:therapeutic use*; D015552:Injections, Intralesional; D008114:Liver Neoplasms, Experimental / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008937:Mitomycins / Q000008:administration & dosage / Q000627:therapeutic use*; D009368:Neoplasm Transplantation; D051381:Rats; D011920:Rats, Inbred WF; D012997:Solvents / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000903:Antibiotics, Antineoplastic; D008937:Mitomycins; D012997:Solvents; D000431:Ethanol; D006821:Hyaluronoglucosaminidase